12:00-1:00 pm EST

Join us for a live discussion with Matthew Hemming, MD, PhD, who will answer your important questions about gynecologic sarcoma from research, to treatment, and survivorship. Submit your questions in advance and join us live to submit your questions in real time. This session will be recorded and available for replay.

Click here to register!

Presenter: Matthew Hemming, MD, PhD

Matthew Hemming, MD, PhD is an Assistant Professor of Medicine in the Division of Hematology/Oncology at UMass Chan Medical School and a medical oncologist at UMass Memorial Medical Center. He received his PhD in 2007 from Harvard University and his MD in 2012 from Harvard Medical School. Dr. Hemming completed his internship and residency in Internal Medicine at Massachusetts General Hospital, followed by fellowship training in Hematology/Oncology at the Dana-Farber/Partners Hematology/Oncology Fellowship Program.

In 2017, Dr. Hemming joined the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute, where he practiced as a physician specializing in adult sarcomas and performed laboratory research focused on sarcoma. In 2022, he was recruited to UMass to establish a dedicated clinical and research program in sarcoma.

Dr. Hemming is a practicing oncologist with expertise in the care of adults with sarcomas, and he leads the Sarcoma Lab at UMass as Principal Investigator. His research program is focused on both pediatric and adult sarcomas, with the goal of advancing biological understanding and developing new therapeutic strategies for these rare and challenging cancers.

Moderated by Liza Lundgren, LCSW, OCRA Director of Education

1:00-2:00 pm ET

Advocacy doesn’t start and end in Washington, DC. Join Julia Thayer, OCRA’s Associate Director of Advocacy, in this introductory webinar that will explore how individuals can engage in ovarian and gynecologic cancer advocacy at the local level and make an impact in their own communities. OCRA will provide a simple overview of how local governments work and share practical ways to get involved — from attending public meetings to building relationships with local officials. This session is ideal for anyone interested in taking their first step into advocacy.

Participants will learn:

• What local advocacy is and why it matters

• How to identify advocacy opportunities in your area

• Practical tools for engaging with local decision-makers and elected officials
• Simple next steps to begin or deepen your advocacy involvement

Click here to register!

This session will be prerecorded and available for replay after the event.

Presented on November 19, 2025

Learn the latest treatment advances for gynecologic cancer from the fall 2025 American Association for Cancer Research (AACR) Special Conference in Cancer Research: Advances in Ovarian Cancer Research, European Society for Medical Oncology (ESMO), and International Gynecologic Cancer Society (IGCS) meetings.

Presenters:

• Anne Mette Buhl, PhD, OCRA’s Senior Director of Treatment Access and Scientific Education

• Ramez Eskander, MD, Professor of Gynecologic Oncology at University of California San Diego Moores NCI-Designated Comprehensive Cancer Center

Presented on June 18, 2025

Learn the latest treatment advances for gynecologic cancer from the spring 2025 meetings of Society of Gynecologic Oncology (SGO) and the American Society of Clinical Oncology (ASCO) meetings.

Presenters:

• Anne Mette Buhl, PhD, OCRA’s Senior Director of Treatment Access and Scientific Education 
• Ramez Eskander, MD, Professor of Gynecologic Oncology at University of California San Diego Moores NCI-Designated Comprehensive Cancer Center

Presented on April 9, 2025

Speakers:

• Ramez Eskander, MD, Professor of Gynecologic Oncology at University of California San Diego Moores NCI-Designated Comprehensive Cancer Center
• Ann Klopp, Professor of Radiation Oncology and head of the Gynecologic Oncology Section in Radiation Oncology at The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.

This event was made possible with support from AstraZeneca and Merck.

Presented on September 19, 2024

Speakers:

• Ying Liu, MD, MPH, Lead, Inherited Gynecologic Cancer Program, Memorial Sloan Kettering Cancer Center
• Barbara Norquist, MD, Associate Professor at the University of Washington, Associate Chair of Research for the Department of Obstetrics and Gynecology, medical director of University of Washington/Fred Hutchinson Cancer Center Breast and Ovarian Cancer Prevention Program

This event was made possible with support from AstraZeneca.